Respiratory syncytial virus: disease, development and treatment

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Respiratory syncytial virus (RSV) is a common infectious agent transmitted via respiratory droplets.
• It frequently causes upper and lower respiratory tract infections, particularly in vulnerable populations.
• RSV infections are typically self-limiting but pose significant risks to infants, young children, and the elderly.

Purpose of the Study:

• To inform healthcare professionals, especially nurses, about the transmission, pathogenesis, and treatment of RSV.
• To emphasize the importance of recognizing and managing RSV in at-risk patient groups.
• To provide an overview of current pharmacological interventions for RSV.

Main Methods:

• Review of existing literature on RSV transmission and clinical manifestations.
• Summary of established treatment protocols, including antiviral therapies.
• Discussion of nursing considerations for patient care and infection control.

Main Results:

• RSV spreads through respiratory droplets, leading to contagious infections.
• The virus commonly affects individuals under five years old and the elderly.
• Antiviral medications represent the primary pharmacological treatment approach.

Conclusions:

• Healthcare providers must be knowledgeable about RSV transmission dynamics and pathogenesis.
• Effective management strategies are crucial for patients susceptible to severe RSV illness.
• Awareness of treatment options, including antivirals, aids in optimal patient care.